Quetiapine May Be Better Option Than Lithium for Treatment-Resistant Depression

[ad_1]

(MedPage Today) — Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter clinical trial suggested.
Over…

[ad_2]

Source link : https://www.medpagetoday.com/psychiatry/depression/114840

Author :

Publish date : 2025-03-26 19:28:00

Copyright for syndicated content belongs to the linked Source.